Biotechnology

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines

by

NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX). The class action, filed in the United States District Court for the Central District of California, and docketed under 24-cv-00337, is on behalf of a class consisting of … Read more

Kling Biotherapeutics to Present Discoveries on its Primary B-Cell Screening Platform at the ESMO Targeted Anticancer Therapies Congress

by

Kling reports on advancing pipeline of therapeutic antibodies targeting novel antigens discovered with its best-in-class B-cell screening platform, Kling-Select Progress on in vitro and in vivo validation of two highly specific tumor antigens is reported: CD43s, a sialylated-glyco epitope, and U5snRNP200, an ectopically expressed antigen highly specific for AML blast Lead program KBA1412 is advancing in … Read more

Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024

by

EMERYVILLE, Calif., Feb. 8, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, … Read more

Más precisión en el tratamiento de tumores gracias a la tecnología superconductora de ASG Superconductors

by

GINEBRA, Italia y DRESDEN, Alemania, 11 de enero de 2024 /PRNewswire/ — La tecnología superconductora MgB2 de ASG Superconductors (ASG), la cual ya se utiliza en aplicaciones energéticas y médicas, siendo el único sistema de resonancias magnéticas (IRM) MROpenEVO verdaderamente abierto del mundo, está en el corazón de la innovación mundial presentada hoy en Dresde … Read more

Global Apoptosis Assays Market Analysis Report 2023: A $5.36 Billion Market in 2022

by

DUBLIN, Jan. 5, 2024 /PRNewswire/ — The “Apoptosis Assays Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. Global Apoptosis Assays Market has valued at USD 5.36 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 9.70% through 2028. … Read more

Japan to Witness Highest Growth During Forecast Period

by

DUBLIN, Jan. 4, 2024 /PRNewswire/ — The “Global Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global Cartilage Repair/Cartilage Regeneration Market is projected to reach USD 2.8 Billion by … Read more

Volition Presents at the 5th Annual Congress of the International Liquid Biopsy Society

by

HENDERSON, Nev, Nov. 17, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, is presenting at the 5th Annual Congress of Liquid Biopsy being held in Madrid, Spain. Lea Payen-Gay, Professor in Toxicology and Biochemistry, University of Lyon I Hospices Civils de Lyon, France and Dr. Jake Micallef, Chief Scientific Officer, Volition … Read more

First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations

by

Investigational TAR-210 first-in-human results highlight the potential for local sustained release of erdafitinib with a novel intravesical delivery system  Phase 1 results show a manageable safety profile with limited systemic toxicity, and early complete responses in patients with high-risk and intermediate-risk NMIBC MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & … Read more

Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

by

New AOC 1001 data demonstrate improvement in additional functional measures including hand grip, muscle strength and patient reported outcomes, augmenting previously reported positive data showing improvements in myotonia, muscle strength and mobility   New long-term safety data of AOC 1001 continue to demonstrate favorable safety and tolerability with over 200 infusions totaling 46.2 patient-years of … Read more

National University Health System Launches World’s First Public Hospital’s Healthy Longevity Clinic at Alexandra Hospital

by

SINGAPORE, Sept. 2, 2023 /PRNewswire/ — The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH) have achieved a milestone by unveiling the world’s inaugural Healthy Longevity Clinic by public healthcare. Located at Singapore’s Alexandra Hospital, the clinic aims to delay biological ageing, thereby optimising functionality and resilience and … Read more